Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| N-(PEG2-C2-acid)-N-bis(PEG2-propargyl) | C21H35NO8 | 2100306-49-6 | Details |
| N-(Propargyl-PEG2)-N-Boc-PEG3-t-butyl ester | C25H45NO9 | 2093152-78-2 | Details |
| N-(PEG3-acid)-N-bis(PEG3-amine) | C25H53N3O11 | 2183440-35-7 | Details |
| N-(Propargyl-PEG4)-N-bis(PEG4-acid) | C33H61NO16 | 2093153-09-2 | Details |
| N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)；n-propargyl-peg4-carbonyl-n-bis-peg1-methyl-ester | C24H41NO11 | 2112732-01-9 | Details |
| N-(Propargyl-PEG4)-biocytin | C28H46N4O9S | 2055042-71-0 | Details |
| Lomefloxacin hydrochloride；Okacyn;Lomefloxacin HCl;Maxaquin | C17H20ClF2N3O3 | 98079-52-8 | Details |
| N-Succinimidyl 3-(Bromoacetamido)propionate；3-(2-Bromoacetamido)propanoic acid NHS ester | C9H11BrN2O5 | 57159-62-3 | Details |
| N-Succinimidyl-S-acetylthioacetate；SATA | C8H9NO5S | 76931-93-6 | Details |
| N-(t-Boc-Aminooxy-PEG2)-N-bis(PEG3-propargyl) | C29H52N2O11 | 2112737-60-5 | Details |
| N3-PEG2-C2-NHS ester | C11H16N4O6 | 1312309-64-0 | Details |
| N3-PEG2-C2-PFP ester | C13H12F5N3O4 | 1393330-37-4 | Details |
| N3-PEG3-C2-NHS ester | C13H20N4O7 | 1245718-89-1 | Details |
| N3-PEG3-C2-PFP ester | C15H16F5N3O5 | 1807530-07-9 | Details |
| N3-PEG3-CH2CH2-Boc | C13H25N3O5 | 252881-73-5 | Details |
| N3-PEG3-CH2CH2COOH | C9H17N3O5 | 1056024-94-2 | Details |
| N3-PEG4-C2-NHS ester | C15H24N4O8 | 944251-24-5 | Details |
| Narlaprevir；SCH 900518 | C36H61N5O7S | 865466-24-6 | Details |
| NB001；HTS 09836 | C12H20N6O | 686301-48-4 | Details |
| NBD-556 | C17H24ClN3O2 | 333353-44-9 | Details |
| NCT-502；N-(4,6-dimethylpyridin-2-yl)-4-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carbothioamide | C18H20F3N5S | 1542213-00-2 | Details |
| NCX1022 | C29H35NO9 | 571186-50-0 | Details |
| Nebicapone；BIA 3-202 | C14H11NO5 | 274925-86-9 | Details |
| Rivastigmine tartrate；ENA 713;SDZ-ENA 713 | C18H28N2O8 | 129101-54-8 | Details |
| Nedocromil；FPL 59002 | C19H17NO7 | 69049-73-6 | Details |
| Nelonicline；ABT-126 | C17H19N3OS | 1026134-63-3 | Details |
| Nemorexant；Daridorexant;ACT-541468 | C23H23ClN6O2 | 1505484-82-1 | Details |
| Neocarzinostatin | 9014-02-2 | Details |
| Neoseptin 3 | C29H34N2O4 | 1622863-21-1 | Details |
| Neosolaniol | C19H26O8 | 36519-25-2 | Details |
| Naminidil；BMS 234303-01 | C15H19N5 | 220641-11-2 | Details |
| NAMI-A | C8H16Cl4N4ORuS | 201653-76-1 | Details |
| Nagilactone B | C19H24O7 | 19891-51-1 | Details |
| Naluzotan；PRX 00023 | C23H38N4O3S | 740873-06-7 | Details |
| N6-Cyclopentyladenosine；CPA;UK-80882 | C15H21N5O4 | 41552-82-3 | Details |
| N33-TEG-COOH；14-Azido-3,6,9,12-tetraoxatetradecanoic acid;N3-TEG-COOH | C10H19N3O6 | 201467-81-4 | Details |
| N3-PEG8-CH2COOH | C18H35N3O10 | 1343472-07-0 | Details |
| N3-PEG4-C2-Pfp ester | C17H20F5N3O6 | 1353012-00-6 | Details |
| Prostaglandin E1；Alprostadil;PGE1 | C20H34O5 | 745-65-3 | Details |
| Napsagatran hydrate；Ro 46-6240/010 hydrate;Ro 46-6240 hydrate | C26H36N6O7S | 159668-20-9 | Details |
| Napropamide；Napropamid | C17H21NO2 | 15299-99-7 | Details |
| Naproxen etemesil；MX 1094;LT-NS 001 | C17H20O5S | 385800-16-8 | Details |
| Nanatinostat；CHR-3996 | C20H19FN6O2 | 1256448-47-1 | Details |
| Nanaomycin A | C16H14O6 | 52934-83-5 | Details |
| Famotidine；MK-208 | C8H15N7O2S3 | 76824-35-6 | Details |
| Namitecan；ST-1968 | C23H22N4O5 | 372105-27-6 | Details |
| N-(Azido-PEG4)-biocytin | C27H47N7O9S | 2055042-70-9 | Details |
| N-(Azido-PEG4)-N-bis(PEG4-acid) | C32H62N4O16 | 2093152-80-6 | Details |
| N-(Azido-PEG4)-N-bis(PEG4-t-butyl ester) | C40H78N4O16 | 2093152-79-3 | Details |
| N-(Azido-PEG4)-N-Boc-PEG4-Boc | C30H58N4O12 | 2112737-20-7 | Details |
| N-(Azido-PEG4)-N-Boc-PEG4-NHS ester | C28H49N5O13 | 2112731-96-9 | Details |
| N-Benzyl-N-bis-PEG2 | C15H25NO4 | 119580-47-1 | Details |
| Pazufloxacin Mesylate；Pazufloxacin mesilate;Pazucross;T-3762;Pazufloxacin methanesulfonate | C17H19FN2O7S | 163680-77-1 | Details |
| N-Benzyl-N-bis-PEG4 | C23H41NO8 | 1680183-01-0 | Details |
| N-(Biotin)-N-bis(PEG1-alcohol) | C18H33N3O6S | 2100306-75-8 | Details |
| N-Boc-diethanolamine | C9H19NO4 | 103898-11-9 | Details |
| N-Boc-N-bis(C2-PEG1-azide) | C13H25N7O4 | 2100306-79-2 | Details |
| N-Boc-N-bis(PEG2-OH) | C13H27NO6 | 275385-03-0 | Details |
| N-Boc-N-bis(PEG2-propargyl) | C19H31NO6 | 2100306-86-1 | Details |
| N-Boc-N-bis(PEG3-azide) | C21H41N7O8 | 1258939-38-6 | Details |
| N-Boc-N-bis(PEG4-azide) | C25H49N7O10 | 2055041-25-1 | Details |
| N-Boc-N-bis(PEG4-OH) | C21H43NO10 | 2093154-01-7 | Details |
| N-Boc-N-bis-PEG5 | C25H51NO12 | 2093154-02-8 | Details |
| Imatinib Mesylate；ST-1571 Mesylate;CGP-57148B;STI-571 | C30H35N7O4S | 220127-57-1 | Details |
| N-(Boc-PEG1)-N-bis(PEG2-propargyl) | C23H40N2O7 | 2100306-63-4 | Details |
| N-Boc-PEG2-bromide | C9H18BrNO3 | 164332-88-1 | Details |
| N-Boc-PEG3-bromide | C11H22BrNO4 | 165963-71-3 | Details |
| N-(Boc-PEG3)-N-bis(PEG2-alcohol) | C25H52N2O11 | 2055042-60-7 | Details |
| N-(Boc-PEG3)-N-bis(PEG3-azide) | C29H57N7O11 | 2182602-15-7 | Details |
| N-Boc-PEG4-bromide | C13H26BrNO5 | 1076199-21-7 | Details |
| N-(Boc-PEG4)-NH-PEG4-NH-Boc | C30H60N2O12 | 2112737-17-2 | Details |
| N-Boc-PEG5-alcohol | C15H31NO7 | 1404111-67-6 | Details |
| N-Boc-PEG5-bromide | C15H30BrNO6 | 1392499-32-9 | Details |
| N-Boc-PEG6-alcohol | C17H35NO8 | 331242-61-6 | Details |
| Rosiglitazone maleate；BRL 49653C;BRL 49653 | C22H23N3O7S | 155141-29-0 | Details |
| N-Boc-PEG7-alcohol | C19H39NO9 | 1292268-13-3 | Details |
| N-Boc-serinol | C8H17NO4 | 125414-41-7 | Details |
| N-Bromoacetyl-β-alanine | C5H8BrNO3 | 89520-11-6 | Details |
| N-Dodecyl-β-D-maltoside；Lauryl Maltoside | C24H46O11 | 69227-93-6 | Details |
| N-(Hydroxy-PEG3)-N-bis(PEG4-Boc) | C38H75NO16 | 2112734-70-8 | Details |
| N-Hydroxysulfosuccinimide sodium | C4H6NNaO6S | 106627-54-7 | Details |
| N-(Ketocaproyl)-DL-homoserine lactone；N-(Ketocaproyl)-D,L-homoserine lactone | C10H15NO4 | 76924-95-3 | Details |
| N-Mal-N-bis(PEG2-acid) | C21H32N2O11 | 2110449-02-8 | Details |
| N-Mal-N-bis(PEG2-amine) | C19H34N4O7 | 2128735-20-4 | Details |
| N-Mal-N-bis(PEG2-C2-Boc) | C29H48N2O11 | 2100306-51-0 | Details |
| Lopinavir；ABT-378 | C37H48N4O5 | 192725-17-0 | Details |
| N-Mal-N-bis(PEG2-NH-Boc) | C29H50N4O11 | 2128735-26-0 | Details |
| N-Mal-N-bis(PEG2-NHS ester) | C29H38N4O15 | 2182601-73-4 | Details |
| N-Mal-N-bis(PEG4-amine) | C27H50N4O11 | 2128735-22-6 | Details |
| N-Mal-N-bis(PEG4-NH-Boc) | C37H66N4O15 | 2128735-27-1 | Details |
| N-Mal-N-bis(PEG4-NHS ester) | C37H54N4O19 | 2112738-60-8 | Details |
| N-(Mal-PEG6)-N-bis(PEG3-amine) | C38H71N5O16 | 2055040-99-6 | Details |
| N-Me-N-bis(PEG2-propargyl) | C15H25NO4 | 1835759-84-6 | Details |
| N-Me-N-bis-PEG4 | C17H37NO8 | 2055046-22-3 | Details |
| N-Methyl-N-(t-Boc)-PEG4-acid | C17H33NO8 | 1260431-01-3 | Details |
| N-Methylisatoic anhydride；NMIA | C9H7NO3 | 10328-92-4 | Details |
| N,N'-Diacetyl-L-cystine；DiNAC;(Ac-Cys-OH)2 | C10H16N2O6S2 | 5545-17-5 | Details |
| N-(NHS-PEG3)-N-bis(PEG3-azide) | C29H52N8O13 | 2182602-16-8 | Details |
| N-(PEG1-OH)-N-Boc-PEG2-propargyl | C16H29NO6 | 2100306-85-0 | Details |
| N-(PEG2-Boc)-N-bis(PEG2-propargyl) | C25H43NO8 | 2100306-69-0 | Details |
| Product Total： Product Page： | ||||
| 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 | ||||